ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO534

Pin1 Isomerase Activity Determines PTH Gene Expression in Uremic Secondary Hyperparathyroidism

Session Information

Category: Bone and Mineral Metabolism

  • 401 Bone and Mineral Metabolism: Basic

Authors

  • Hassan, Alia, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Levin, Rachel, Jerusalem College of Technology, Jerusalem, Israel
  • Silver, Justin, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Nechama, Morris, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Naveh-Many, Tally, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Background

Secondary hyperparathyroidism (SHP) is a common complication of CKD that correlates with morbidity and mortality. In experimental SHP there is increased PTH secretion, gene expression and parathyroid cell proliferation. The high PTH gene expression is due to increased PTH mRNA stability mediated by the balanced protein-PTH mRNA interaction of AUF1 (AU-rich binding protein 1) that stabilizes and KSRP (K-homology splicing regulatory protein) that destabilizes PTH mRNA. Pin1 binds to and isomerizes phosphorylated Ser/Thr-Pro motifs in target proteins, including mRNA binding proteins. Pin1-KSRP interaction leads to dephosphorylation of KSRP at Ser181 that then binds to PTH mRNA with higher affinity to induce PTH mRNA decay. In SHP, Pin1 isomerase activity is decreased and phosphorylated KSRP fails to bind PTH mRNA, resulting in increased PTH mRNA stability and levels. Pin1 activity is regulated by phosphorylation at Ser16 and Ser71 that disrupts its interaction with target proteins and catalytic isomerase activity.

Methods

We performed proteome and phospho-proteome analysis of parathyroids from normal and adenine high phosphorus induced CKD rats. Pin1 phosphorylation was demonstrated by immunofluorescence staining. The PKA activator forskolin or PKA inhibitor H89 were added to mouse thyroparathyroid glands in culture or HEK293 cells transfected with a PTH expression plasmid. Secreted PTH was measured by Elisa and mRNA levels by qRT-PCR.

Results

Phospho-proteome analysis confirmed KSRP hyper-phosphorylation in parathyroids of SHP rats, that would prevent PTH mRNA-KSRP binding and decay. It also identified new Pin1 targets and signaling pathways. Phosphorylation of both Pin1 Ser16 and Ser71 was increased in parathyroids of SHP rats, correlating with the decreased Pin1 activity. Accordingly, parathyroid extracts from SHP rats showed increased in vitro phosphorylation activity towards recombinant GST-Pin1. PKA activation, that leads to Pin1 Ser16 phosphorylation, increased PTH secretion in parathyroid organ cultures and PTH mRNA in transfected HEK293 cells. PKA inhibition had the opposite effect.

Conclusion

Pin1 activity is central to the pathogenesis of SHP by orchestrating PTH mRNA-protein interaction and thus mRNA decay. The resulting increased PTH mRNA stability leads to the high serum PTH levels in SHP.

Funding

  • Government Support - Non-U.S.